Ndufa6 regulates adipogenic differentiation via Scd1

Jingwei Zhang, Wei Wang1, Ninghan Feng1,2

  • 1Department of metabolism, Wuxi School of Medicine, Jiangnan University, Wuxi, China.

Adipocyte
|November 18, 2021
PubMed

Insights

Researchers identified NADH:ubiquinone oxidoreductase subunit A6 (Ndufa6) as a key regulator in fat cell formation (adipogenesis). Targeting the NDUFA6-SCD1 pathway may offer new obesity treatments.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Diseases

Background:

  • Obesity is a global pandemic with serious health complications.
  • Inhibiting adipogenesis, the process of fat cell formation, is a key strategy for obesity treatment.
  • The precise molecular mechanisms governing adipogenesis are not fully understood, leaving potential therapeutic targets undiscovered.

Purpose of the Study:

  • To investigate the functional genes regulating adipogenic differentiation.
  • To elucidate the molecular mechanisms underlying adipogenesis.
  • To identify novel therapeutic targets for obesity treatment.

Main Methods:

  • Utilized transcriptomics and lipidomics to analyze gene expression and lipid profiles.
  • Employed OP9 cells and adipose-derived stem cells for experimental models.
  • Investigated the role of NADH:ubiquinone oxidoreductase subunit A6 (Ndufa6) in adipogenesis.

Main Results:

  • Identified Ndufa6 as a significant regulator of adipogenic differentiation.
  • Demonstrated that Ndufa6 exerts its effects via stearoyl-CoA desaturase 1 (Scd1).
  • Confirmed the inhibitory effect of a SCD1 inhibitor on adipogenesis.

Conclusions:

  • Ndufa6 plays a crucial role in regulating adipogenesis.
  • The NDUFA6-SCD1 axis represents a novel pathway in adipogenesis.
  • The NDUFA6-SCD1 interaction presents a potential therapeutic target for managing obesity.